Component

SARS-CoV-2 viral RNA in Vero-hSLAM culture

Viral RNA measured in a monkey kidney cell line.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. A single addition of ivermectin to SARS-CoV-2-infected Vero-hSLAM cells two hours after infection produced approximately a five thousand fold reduction in viral RNA at forty-eight hours.

    Experimental context and source evidence
    duration
    48 hours
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    experimental_model
    Vero-hSLAM cell culture
    exposure
    Single ivermectin addition two hours post infection
    limitations
    This is a cell-culture result in a monkey kidney line, and the authors state only that it warrants further investigation for possible benefits in humans. The concentration relationship to human plasma exposure is not addressed in the report and remains unresolved here.
    organism
    Vero-hSLAM cell culture
    plain_language
    A single addition of ivermectin to SARS-CoV-2-infected Vero-hSLAM cells two hours after infection produced approximately a five thousand fold reduction in viral RNA at forty-eight hours.
    primary_references
    The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. (2020). https://pubmed.ncbi.nlm.nih.gov/32251768/ DOI: 10.1016/j.antiviral.2020.104787
    route
    In vitro
    tissue
    Viral RNA

    Ivermectin: mechanism of action across parasite, host barrier and mammalian targets (2026-09-22) · lines 167–176

    Original AI-assisted curation of sixteen primary studies resolved by PubMed title search and cross-checked against live PubMed metadata. Study-specific citations, concentrations, negative findings and limitations retained. Not publisher full text. · supports · · source_derived_draft · unverified_draft

    ## ivermectin-sars-cov-2-cell-culture A single addition of ivermectin to SARS-CoV-2-infected Vero-hSLAM cells two hours after infection produced approximately a five thousand fold reduction in viral RNA at forty-eight hours. Model/species: Vero-hSLAM cell culture Tissue/system: Viral RNA Exposure: Single ivermectin addition two hours post infection Route: In vitro Duration: 48 hours Limits: This is a cell-culture result in a monkey kidney line, and the authors state only that it warrants further investigation for possible benefits in humans. The concentration relationship to human plasma exposure is not addressed in the report and remains unresolved here. Primary reference: The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. (2020). https://pubmed.ncbi.nlm.nih.gov/32251768/ DOI: 10.1016/j.antiviral.2020.104787 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards